S J Connolly

Summary

Country: Canada

Publications

  1. ncbi The North American Vasovagal Pacemaker Study (VPS). A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope
    S J Connolly
    Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    J Am Coll Cardiol 33:16-20. 1999
  2. ncbi Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone
    S J Connolly
    Departments of Medicine, McMaster University, Hamilton, Ontario, Canada
    Circulation 101:1297-302. 2000
  3. ncbi Appropriate outcome measures in trials evaluating treatment of atrial fibrillation
    S J Connolly
    McMaster University, Hamilton, Canada
    Am Heart J 139:752-60. 2000
  4. ncbi Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. Canadian Trial of Physiologic Pacing Investigators
    S J Connolly
    Department of Medicine, McMaster University, Hamilton, Ont, Canada
    N Engl J Med 342:1385-91. 2000
  5. doi Irbesartan in patients with atrial fibrillation
    Salim Yusuf
    Population Health Research Institute, McMaster University, Hamilton, ON, Canada
    N Engl J Med 364:928-38. 2011
  6. doi Apixaban in patients with atrial fibrillation
    Stuart J Connolly
    Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON, Canada
    N Engl J Med 364:806-17. 2011
  7. ncbi Cost-effectiveness of the implantable cardioverter-defibrillator: results from the Canadian Implantable Defibrillator Study (CIDS)
    S J Connolly
    Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada
    Circulation 103:1416-21. 2001
  8. doi Effect of a simple two-step warfarin dosing algorithm on anticoagulant control as measured by time in therapeutic range: a pilot study
    Y K Kim
    Department of Medicine, McMaster University, and Population Health Research Institute, Hamilton, ON, Canada
    J Thromb Haemost 8:101-6. 2010
  9. ncbi Dose-response relations of azimilide in the management of symptomatic, recurrent, atrial fibrillation
    S J Connolly
    Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    Am J Cardiol 88:974-9. 2001
  10. doi Randomised comparison of a simple warfarin dosing algorithm versus a computerised anticoagulation management system for control of warfarin maintenance therapy
    Robby Nieuwlaat
    Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada
    Thromb Haemost 108:1228-35. 2012

Collaborators

Detail Information

Publications13

  1. ncbi The North American Vasovagal Pacemaker Study (VPS). A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope
    S J Connolly
    Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    J Am Coll Cardiol 33:16-20. 1999
    ..This study was done to evaluate pacemaker therapy for severe recurrent vasovagal syncope...
  2. ncbi Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone
    S J Connolly
    Departments of Medicine, McMaster University, Hamilton, Ontario, Canada
    Circulation 101:1297-302. 2000
    ..The implantable cardioverter defibrillator (ICD) terminates VT or VF, but it is not known whether this device prolongs life in these patients compared with medical therapy with amiodarone...
  3. ncbi Appropriate outcome measures in trials evaluating treatment of atrial fibrillation
    S J Connolly
    McMaster University, Hamilton, Canada
    Am Heart J 139:752-60. 2000
    ..Atrial fibrillation (AF) is a widespread disease that has only recently received the focused attention of arrhythmia specialists despite being the most frequently occurring significant cardiac arrhythmia...
  4. ncbi Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. Canadian Trial of Physiologic Pacing Investigators
    S J Connolly
    Department of Medicine, McMaster University, Hamilton, Ont, Canada
    N Engl J Med 342:1385-91. 2000
    ..These benefits have not been evaluated in a large, randomized, controlled trial...
  5. doi Irbesartan in patients with atrial fibrillation
    Salim Yusuf
    Population Health Research Institute, McMaster University, Hamilton, ON, Canada
    N Engl J Med 364:928-38. 2011
    ..The risk of cardiovascular events among patients with atrial fibrillation is high. We evaluated whether irbesartan, an angiotensin-receptor blocker, would reduce this risk...
  6. doi Apixaban in patients with atrial fibrillation
    Stuart J Connolly
    Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON, Canada
    N Engl J Med 364:806-17. 2011
    ..Apixaban, a novel factor Xa inhibitor, may be an alternative treatment for such patients...
  7. ncbi Cost-effectiveness of the implantable cardioverter-defibrillator: results from the Canadian Implantable Defibrillator Study (CIDS)
    S J Connolly
    Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada
    Circulation 103:1416-21. 2001
    ..Further research is warranted to identify the indications and patient subgroups for whom ICDs are a cost-effective use of resources...
  8. doi Effect of a simple two-step warfarin dosing algorithm on anticoagulant control as measured by time in therapeutic range: a pilot study
    Y K Kim
    Department of Medicine, McMaster University, and Population Health Research Institute, Hamilton, ON, Canada
    J Thromb Haemost 8:101-6. 2010
    ....
  9. ncbi Dose-response relations of azimilide in the management of symptomatic, recurrent, atrial fibrillation
    S J Connolly
    Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    Am J Cardiol 88:974-9. 2001
    ..9% of patients receiving either of the 2 effective doses. Thus, doses of azimilide <100 mg/day are not effective for control of AF, whereas doses of 100 and 125 mg/day are effective with an acceptable risk of serious toxicity...
  10. doi Randomised comparison of a simple warfarin dosing algorithm versus a computerised anticoagulation management system for control of warfarin maintenance therapy
    Robby Nieuwlaat
    Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada
    Thromb Haemost 108:1228-35. 2012
    ..4% to 4.1%]; p-value for non-inferiority=0.002; p-value for superiority=0.34). In conclusion, similar maintenance control of the INR was achieved with a simple one-step dosing algorithm and a commercial computerised management system...
  11. doi Defibrillation testing at the time of ICD insertion: an analysis from the Ontario ICD Registry
    J S Healey
    Population Health Research Institute and McMaster University, Hamilton, Canada
    J Cardiovasc Electrophysiol 21:1344-8. 2010
    ..increasingly, ICD implantation is performed without defibrillation testing (DT)...
  12. doi Dabigatran versus warfarin in patients with atrial fibrillation
    Stuart J Connolly
    Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON, Canada
    N Engl J Med 361:1139-51. 2009
    ..Warfarin reduces the risk of stroke in patients with atrial fibrillation but increases the risk of hemorrhage and is difficult to use. Dabigatran is a new oral direct thrombin inhibitor...
  13. pmc Effects of magnesium on atrial fibrillation after cardiac surgery: a meta-analysis
    S Miller
    Arrhythmia Services, Schulich Heart Centre, Department of Medicine, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
    Heart 91:618-23. 2005
    ..To assess the efficacy of the administration of magnesium as a method for the prevention of postoperative atrial fibrillation (AF) and to evaluate its influence on hospital length of stay (LOS) and mortality...